APA (7th ed.) Citation

R, C., J, H., C, C., Z, Y., & B, C. (2025). Efficacy and Safety of Dupilumab in the Treatment of Refractory Atopic Dermatitis in Older Adults: A Retrospective, Single-Center Study. Drugs & aging, 42(4), 363. https://doi.org/10.1007/s40266-025-01193-6

Chicago Style (17th ed.) Citation

R, Cai, Huang J, Chen C, Ye Z, and Cheng B. "Efficacy and Safety of Dupilumab in the Treatment of Refractory Atopic Dermatitis in Older Adults: A Retrospective, Single-Center Study." Drugs & Aging 42, no. 4 (2025): 363. https://doi.org/10.1007/s40266-025-01193-6.

MLA (9th ed.) Citation

R, Cai, et al. "Efficacy and Safety of Dupilumab in the Treatment of Refractory Atopic Dermatitis in Older Adults: A Retrospective, Single-Center Study." Drugs & Aging, vol. 42, no. 4, 2025, p. 363, https://doi.org/10.1007/s40266-025-01193-6.